MX2021015830A - Formulaciones penetrantes transdermicas. - Google Patents
Formulaciones penetrantes transdermicas.Info
- Publication number
- MX2021015830A MX2021015830A MX2021015830A MX2021015830A MX2021015830A MX 2021015830 A MX2021015830 A MX 2021015830A MX 2021015830 A MX2021015830 A MX 2021015830A MX 2021015830 A MX2021015830 A MX 2021015830A MX 2021015830 A MX2021015830 A MX 2021015830A
- Authority
- MX
- Mexico
- Prior art keywords
- transdermal delivery
- transdermal
- formulation
- formulations
- transdermal penetrant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Abstract
Se divulga en la presente una formulación de suministro transdérmico para suministro transdérmicode un agente activo a través de la piel, uña o folículo capilar de un sujeto, en donde la formulación comprende a) una formulación de suministro transdérmico en una cantidad menor que aproximadamente 60 % p/p, que comprende i. uno o más fosfátidos, ii. glucosa, y iii. uno o más ácidos grasos; y b) agua en una cantidad menor que aproximadamente 50 % p/p.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962863242P | 2019-06-18 | 2019-06-18 | |
PCT/US2020/038558 WO2020257537A1 (en) | 2019-06-18 | 2020-06-18 | Transdermal penetrant formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021015830A true MX2021015830A (es) | 2022-04-11 |
Family
ID=74040682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021015830A MX2021015830A (es) | 2019-06-18 | 2020-06-18 | Formulaciones penetrantes transdermicas. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220105062A1 (es) |
EP (1) | EP3986464A4 (es) |
JP (1) | JP2022537711A (es) |
KR (1) | KR20220054284A (es) |
CN (1) | CN115379859A (es) |
AU (1) | AU2020298248A1 (es) |
BR (1) | BR112021025545A2 (es) |
CA (1) | CA3144006A1 (es) |
IL (1) | IL289047A (es) |
MA (1) | MA56543A (es) |
MX (1) | MX2021015830A (es) |
WO (1) | WO2020257537A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220202844A1 (en) * | 2020-12-31 | 2022-06-30 | Richard Clark Kaufman | Drug delivery composition and a method of administering the drug |
WO2022155341A1 (en) * | 2021-01-13 | 2022-07-21 | Dyve Biosciences, Inc. | Transdermal formulations for phosphodiesterase-5 inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009092040A2 (en) * | 2008-01-17 | 2009-07-23 | Gary Dean Bennett | Topical pain formulation |
ES2809460T3 (es) * | 2014-10-30 | 2021-03-04 | Delta Fly Pharma Inc | Nuevo método de producción de lipoplejo para administración local y fármaco antitumoral que utiliza lipoplejo |
KR20170110083A (ko) * | 2014-12-23 | 2017-10-10 | 인털렉츄얼 프라퍼티 어쏘시에이츠, 엘엘씨 | 경피 투여를 위한 방법 및 제형 |
US20190021988A1 (en) * | 2016-01-23 | 2019-01-24 | Bruce J. Sand | Enhanced transdermal delivery of active agents |
US20190083386A1 (en) * | 2017-09-15 | 2019-03-21 | Ampersand Biopharmaceuticals, Inc. | Methods and formulations for transdermal administration of buffering agents |
JP2022504250A (ja) * | 2018-10-05 | 2022-01-13 | アンパサンド バイオファーマシューティカルズ インコーポレイテッド | ケトンの経皮投与のための製剤および方法 |
WO2020073030A1 (en) * | 2018-10-05 | 2020-04-09 | Ampersand Biopharmaceuticals, Inc. | Iron formulations for topical administration and methods of treatment of iron deficiency |
EP3870225A1 (en) * | 2018-10-23 | 2021-09-01 | Ampersand Biopharmaceuticals, Inc. | Methods and formulations for transdermal administration of dermal contouring agents |
-
2020
- 2020-06-18 KR KR1020227001704A patent/KR20220054284A/ko unknown
- 2020-06-18 MA MA056543A patent/MA56543A/fr unknown
- 2020-06-18 AU AU2020298248A patent/AU2020298248A1/en active Pending
- 2020-06-18 WO PCT/US2020/038558 patent/WO2020257537A1/en unknown
- 2020-06-18 CA CA3144006A patent/CA3144006A1/en active Pending
- 2020-06-18 MX MX2021015830A patent/MX2021015830A/es unknown
- 2020-06-18 EP EP20825505.9A patent/EP3986464A4/en not_active Withdrawn
- 2020-06-18 JP JP2021574170A patent/JP2022537711A/ja active Pending
- 2020-06-18 BR BR112021025545A patent/BR112021025545A2/pt not_active Application Discontinuation
- 2020-06-18 CN CN202080058184.0A patent/CN115379859A/zh active Pending
-
2021
- 2021-12-16 IL IL289047A patent/IL289047A/en unknown
- 2021-12-17 US US17/554,449 patent/US20220105062A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN115379859A (zh) | 2022-11-22 |
JP2022537711A (ja) | 2022-08-29 |
US20220105062A1 (en) | 2022-04-07 |
MA56543A (fr) | 2022-04-27 |
IL289047A (en) | 2022-02-01 |
WO2020257537A1 (en) | 2020-12-24 |
KR20220054284A (ko) | 2022-05-02 |
CA3144006A1 (en) | 2020-12-24 |
EP3986464A4 (en) | 2023-07-05 |
BR112021025545A2 (pt) | 2022-02-22 |
AU2020298248A1 (en) | 2022-02-03 |
EP3986464A1 (en) | 2022-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8147815B2 (en) | Topical administration carrier composition and therapeutic formulations comprising same | |
CN106176270B (zh) | 一种温和的氨基酸洗发水及其制备方法 | |
AR052192A1 (es) | Composiciones de microemulsion libre de alcohol | |
AR019997A1 (es) | Sistema de administracion topica para agentes activos | |
MX2021015830A (es) | Formulaciones penetrantes transdermicas. | |
TW200735897A (en) | HFSH aqueous formulation | |
MY135988A (en) | Additive for improving the water resistance of cosmetic or dermatological formulations | |
WO2009015913A3 (de) | Naturkosmetisches haarbehandlungsmittel | |
MX2018005743A (es) | Composicion de limpieza para el cuidado de mascotas. | |
CN1787806A (zh) | 皮肤病的局部治疗 | |
KR20020007207A (ko) | 피부의 국소 치료법 | |
DK1313511T3 (da) | Testosteronesterformulering til human brug | |
PH12018500910A1 (en) | Novel method of use and compositions | |
KR101937072B1 (ko) | 다한증 치료용 외용제 | |
ES2137125B1 (es) | La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal. | |
BR112022011909A2 (pt) | Compostos de ácido graxo poliméricos não iônicos para o tratamento de substratos à base de aminoácidos fibrosos, especialmente cabelos | |
KR102164151B1 (ko) | 육모제 조성물 | |
MY194346A (en) | Formulations containing active oxygen compounds and devices for application thereof | |
MX2020010747A (es) | Formulaciones topicas que comprenden estroncio y metilsulfonilmetano (msm) y metodos de tratamiento. | |
CU22866A3 (es) | Formulación farmacéutica semisólida que contiene dexcetoprofentrometamol y procedimiento de obtención | |
MX2020010498A (es) | Composiciones para el cuidado de la piel y sus aplicaciones. | |
FR3068217B1 (fr) | Agent de conservation comprenant de la 4-(3-ethoxy-4-hydroxyphenyl)-2-butanone, et son utilisation dans des compositions cosmetiques | |
CL2017002601A1 (es) | Composición para formulación cosmética humectante de larga duración que comprende manteca de ucuuba (virola surinamensis), en una concentración de 1-5% del total de manteca y altas concentraciones de ácido mirístico así como su uso para la preparación de productos cosméticos (con efecto de tacto seco y pulverulento) con alta capacidad humectante y kit. | |
JP6524366B1 (ja) | 毛髪処理方法 | |
US6528072B1 (en) | Topical composition for skin including witch hazel |